|
US20100130737A1
(en)
*
|
2005-02-18 |
2010-05-27 |
Takeda Pharmaceutical Company Limited |
Regulating Agent of GPR34 Receptor Function
|
|
WO2008030618A1
(en)
*
|
2006-09-07 |
2008-03-13 |
Amgen Inc. |
Benzo-fused compounds for use in treating metabolic disorders
|
|
EP2064193A1
(en)
*
|
2006-09-07 |
2009-06-03 |
Amgen, Inc |
Heterocyclic gpr40 modulators
|
|
WO2008130514A1
(en)
*
|
2007-04-16 |
2008-10-30 |
Amgen Inc. |
Substituted biphenyl phenoxy-, thiophenyl- and aminophenylpropanoic acid gpr40 modulators
|
|
EP2025674A1
(de)
|
2007-08-15 |
2009-02-18 |
sanofi-aventis |
Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
|
KR20100090249A
(ko)
|
2007-10-10 |
2010-08-13 |
암젠 인크 |
치환된 비페닐 ｇｒｐ４０ 조절제
|
|
EP2215068B1
(en)
*
|
2007-10-29 |
2012-06-13 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
|
EP2260017A1
(en)
*
|
2008-03-06 |
2010-12-15 |
Amgen, Inc |
Conformationally constrained carboxylic acid derivatives useful for treating metabolic disorders
|
|
KR20220084423A
(ko)
|
2008-07-23 |
2022-06-21 |
아레나 파마슈티칼스, 인크. |
자가면역성 및 염증성의 장애의 치료에 유용한 치환된 1,2,3,4-테트라히드로시클로펜타[ｂ]인돌-3-일)아세트산 유도체
|
|
JP2012503595A
(ja)
*
|
2008-07-28 |
2012-02-09 |
シダンスク ユニバーシティ |
代謝病の治療用の化合物
|
|
BRPI0917923B1
(pt)
*
|
2008-08-27 |
2022-04-05 |
Arena Pharmaceuticals Inc |
Derivado de ácido tricíclico substituído, sua composição, seu uso e processo para preparar a referida composição
|
|
CA2739888C
(en)
*
|
2008-10-15 |
2013-11-19 |
Amgen Inc. |
Spirocyclic gpr40 modulators
|
|
EP2690095A1
(en)
*
|
2008-10-21 |
2014-01-29 |
Camabay Therapeutics, Inc. |
Aryl gpr120 receptor agonists and uses thereof
|
|
AR074760A1
(es)
*
|
2008-12-18 |
2011-02-09 |
Metabolex Inc |
Agonistas del receptor gpr120 y usos de los mismos en medicamentos para el tratamiento de diabetes y el sindrome metabolico.
|
|
EP2389226B1
(en)
*
|
2009-01-23 |
2013-11-20 |
Merck Sharp & Dohme Corp. |
Bridged and fused heterocyclic antidiabetic compounds
|
|
AU2010240142A1
(en)
*
|
2009-04-22 |
2011-11-10 |
Astellas Pharma Inc. |
Carboxylic acid compound
|
|
JP5856980B2
(ja)
|
2010-01-27 |
2016-02-10 |
アリーナ ファーマシューティカルズ， インコーポレイテッド |
（Ｒ）−２−（７−（４−シクロペンチル−３−（トリフルオロメチル）ベンジルオキシ）−１，２，３，４−テトラヒドロシクロペンタ［ｂ］インドール−３−イル）酢酸およびその塩の調製のためのプロセス
|
|
WO2011107494A1
(de)
|
2010-03-03 |
2011-09-09 |
Sanofi |
Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
|
|
CA2789480A1
(en)
|
2010-03-03 |
2011-09-09 |
Arena Pharmaceuticals, Inc. |
Processes for the preparation of s1p1 receptor modulators and crystalline forms thereof
|
|
EP2582674B1
(en)
*
|
2010-06-16 |
2014-10-01 |
Cymabay Therapeutics, Inc. |
Gpr120 receptor agonists and uses thereof
|
|
US8933024B2
(en)
|
2010-06-18 |
2015-01-13 |
Sanofi |
Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases
|
|
US8530413B2
(en)
|
2010-06-21 |
2013-09-10 |
Sanofi |
Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
|
|
TW201215388A
(en)
|
2010-07-05 |
2012-04-16 |
Sanofi Sa |
(2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
|
|
TW201215387A
(en)
|
2010-07-05 |
2012-04-16 |
Sanofi Aventis |
Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
|
|
TW201221505A
(en)
|
2010-07-05 |
2012-06-01 |
Sanofi Sa |
Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
|
|
US8871758B2
(en)
|
2011-03-08 |
2014-10-28 |
Sanofi |
Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
|
|
US8828995B2
(en)
|
2011-03-08 |
2014-09-09 |
Sanofi |
Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
|
|
US8828994B2
(en)
|
2011-03-08 |
2014-09-09 |
Sanofi |
Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
|
|
US8901114B2
(en)
|
2011-03-08 |
2014-12-02 |
Sanofi |
Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof
|
|
EP2683699B1
(de)
|
2011-03-08 |
2015-06-24 |
Sanofi |
Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
EP2511273B8
(en)
*
|
2011-04-15 |
2019-06-26 |
Hivih |
Inhibitors of viral replication, their process of preparation and their therapeutical uses
|
|
WO2013037390A1
(en)
|
2011-09-12 |
2013-03-21 |
Sanofi |
6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
|
|
WO2013045413A1
(en)
|
2011-09-27 |
2013-04-04 |
Sanofi |
6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
|
|
AU2012365706B2
(en)
*
|
2012-01-12 |
2015-08-20 |
Jiangsu Hengrui Medicine Co., Ltd. |
Polycyclic derivatives, preparation method and medical uses thereof
|
|
MX2014012741A
(es)
|
2012-04-26 |
2015-04-13 |
Bristol Myers Squibb Co |
Derivados de imidazotiadiazol e imidazopirazina como inhibidores del receptor 4 activado de proteasa (par4) para tratamiento de agregacion plaquetaria.
|
|
SI3243826T1
(sl)
|
2012-04-26 |
2020-03-31 |
Bristol-Myers Squibb Company |
Derivati imidazotiadiazola in imidazopirazina kot proteazno aktivirani receptor 4 (PAR4) inhibitorji za zdravljenje agregacije trombocitov
|
|
US9862730B2
(en)
|
2012-04-26 |
2018-01-09 |
Bristol-Myers Squibb Company |
Imidazothiadiazole derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation
|
|
EP2880028B1
(en)
|
2012-08-02 |
2020-09-30 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
|
US20150297573A1
(en)
|
2012-10-24 |
2015-10-22 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
TPL2 KINASE INHIBITORS FOR PREVENTING OR TREATING DIABETES AND FOR PROMOTING Beta-CELL SURVIVAL
|
|
CN104812748B
(zh)
|
2012-11-16 |
2017-10-24 |
百时美施贵宝公司 |
二氢吡唑gpr40调节剂
|
|
WO2014122067A1
(en)
*
|
2013-02-06 |
2014-08-14 |
Boehringer Ingelheim International Gmbh |
New indanyloxydihydrobenzofuranylacetic acids
|
|
EP2958562B1
(en)
|
2013-02-22 |
2025-09-10 |
Merck Sharp & Dohme LLC |
Antidiabetic bicyclic compounds
|
|
US9643946B2
(en)
*
|
2013-02-28 |
2017-05-09 |
Sk Chemicals Co., Ltd. |
Tricyclic compound and use thereof
|
|
CN104109115B
(zh)
*
|
2013-04-16 |
2016-11-23 |
中国科学院上海药物研究所 |
一种含氮杂环链接的苯丙酸类化合物、其药物组合物、制备方法和用途
|
|
EP2821104A1
(en)
|
2013-07-05 |
2015-01-07 |
Laboratoire Biodim |
Inhibitors of viral replication, their process of preparation and their therapeutical uses
|
|
CN105246875A
(zh)
*
|
2013-09-03 |
2016-01-13 |
四川海思科制药有限公司 |
茚满衍生物及其制备方法和在医药上的应用
|
|
WO2015051496A1
(en)
|
2013-10-08 |
2015-04-16 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
|
WO2015073342A1
(en)
*
|
2013-11-15 |
2015-05-21 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
|
WO2015084692A1
(en)
|
2013-12-04 |
2015-06-11 |
Merck Sharp & Dohme Corp. |
Antidiabetic bicyclic compounds
|
|
WO2015089809A1
(en)
|
2013-12-19 |
2015-06-25 |
Merck Sharp & Dohme Corp. |
Antidiabetic substituted heteroaryl compounds
|
|
EP3102198B1
(en)
|
2014-02-06 |
2020-08-26 |
Merck Sharp & Dohme Corp. |
Antidiabetic compounds
|
|
WO2015176267A1
(en)
|
2014-05-22 |
2015-11-26 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
|
WO2016022446A1
(en)
|
2014-08-08 |
2016-02-11 |
Merck Sharp & Dohme Corp. |
[5,6]-fused bicyclic antidiabetic compounds
|
|
WO2016019587A1
(en)
|
2014-08-08 |
2016-02-11 |
Merck Sharp & Dohme Corp. |
[7, 6]-fused bicyclic antidiabetic compounds
|
|
EP3177282B1
(en)
|
2014-08-08 |
2021-10-06 |
Merck Sharp & Dohme Corp. |
Antidiabetic bicyclic compounds
|
|
EP3177287B1
(en)
|
2014-08-08 |
2022-02-23 |
Merck Sharp & Dohme Corp. |
Antidiabetic bicyclic compounds
|
|
EP4445956A3
(en)
|
2015-01-06 |
2024-12-04 |
Arena Pharmaceuticals, Inc. |
Compound for use in treating conditions related to the s1p1 receptor
|
|
ES2805743T3
(es)
|
2015-03-24 |
2021-02-15 |
Inst Nat Sante Rech Med |
Método y composición farmacéutica para uso en el tratamiento de la diabetes
|
|
EP3310760B8
(en)
|
2015-06-22 |
2022-10-19 |
Arena Pharmaceuticals, Inc. |
Crystalline l-arginine salt of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta[b]indol-3-yl)acetic acid for use in s1p1 receptor-associated disorders
|
|
LT3344248T
(lt)
|
2015-09-02 |
2022-06-27 |
Trevena, Inc. |
6-narių azaheterociklinių junginių, kurių sudėtyje yra deltaopioidų receptorius moduliuojančių junginių, panaudojimo ir gamybos būdai
|
|
US10676458B2
(en)
|
2016-03-29 |
2020-06-09 |
Merch Sharp & Dohne Corp. Rahway |
Antidiabetic bicyclic compounds
|
|
KR102364344B1
(ko)
|
2016-05-23 |
2022-02-18 |
인스티튜드 오브 머테리아 메디카, 차이니스 아케데미 오브 메디컬 싸이언시스 |
니코티닐 알콜 에테르 유도체, 그의 제조 방법, 및 그의 약학적 조성물 및 용도
|
|
WO2018106518A1
(en)
|
2016-12-06 |
2018-06-14 |
Merck Sharp & Dohme Corp. |
Antidiabetic heterocyclic compounds
|
|
EP3558298A4
(en)
|
2016-12-20 |
2020-08-05 |
Merck Sharp & Dohme Corp. |
ANTIDIABETIC SPIROCHROMAN COMPOUNDS
|
|
CA3053416A1
(en)
|
2017-02-16 |
2018-08-23 |
Arena Pharmaceuticals, Inc. |
Compounds and methods for treatment of inflammatory bowel disease with extra-intestinal manifestations
|
|
EP3582772A1
(en)
|
2017-02-16 |
2019-12-25 |
Arena Pharmaceuticals, Inc. |
Compounds and methods for treatment of primary biliary cholangitis
|
|
EP3582779B1
(en)
|
2017-02-17 |
2024-04-17 |
Trevena, Inc. |
5-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same
|
|
WO2018152286A1
(en)
|
2017-02-17 |
2018-08-23 |
Trevena, Inc. |
7-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same
|
|
AR111199A1
(es)
*
|
2017-03-31 |
2019-06-12 |
Takeda Pharmaceuticals Co |
Compuesto aromático agonista de gpr40
|
|
CN109320483A
(zh)
*
|
2017-08-01 |
2019-02-12 |
南京大学 |
香豆素衍生物、其制备方法及其作为药物的用途
|
|
PL3684767T3
(pl)
|
2017-09-22 |
2024-10-14 |
Jubilant Epipad LLC |
Związki heterocykliczne jako inhibitory pad
|
|
PL3697785T3
(pl)
|
2017-10-18 |
2023-08-07 |
Jubilant Epipad LLC |
Związki imidazopirydynowe jako inhibitory pad
|
|
AU2018362046B2
(en)
|
2017-11-06 |
2023-04-13 |
Jubilant Prodel LLC |
Pyrimidine derivatives as inhibitors of PD1/PD-L1 activation
|
|
EP3709995A4
(en)
|
2017-11-16 |
2021-04-14 |
Merck Sharp & Dohme Corp. |
Antidiabetic bicyclic compounds
|
|
SI3704120T1
(sl)
|
2017-11-24 |
2024-07-31 |
Jubilant Episcribe Llc |
Heterociklične spojine kot inhibitorji prmt5
|
|
MX2020008404A
(es)
|
2018-02-13 |
2020-09-25 |
Gilead Sciences Inc |
Inhibidores de molecula de muerte programada 1 (pd-1)/ligando de molecula de muerte programada 1 (pd-l1).
|
|
EP3765453A1
(en)
|
2018-03-13 |
2021-01-20 |
Jubilant Prodel LLC |
Bicyclic compounds as inhibitors of pd1/pd-l1 interaction/activation
|
|
ES3035911T3
(en)
|
2018-04-19 |
2025-09-11 |
Gilead Sciences Inc |
Pd-1/pd-l1 inhibitors
|
|
KR102859841B1
(ko)
|
2018-06-06 |
2025-09-12 |
아레나 파마슈티칼스, 인크. |
S1p1 수용체와 관련된 병태의 치료 방법
|
|
SI3820572T1
(sl)
|
2018-07-13 |
2023-12-29 |
Gilead Sciences, Inc. |
Inhibitorji pd-1/pd-l1
|
|
KR102836433B1
(ko)
|
2018-09-06 |
2025-07-21 |
아레나 파마슈티칼스, 인크. |
자가면역 및 염증성 장애의 치료에 유용한 화합물
|
|
JP7158577B2
(ja)
|
2018-10-24 |
2022-10-21 |
ギリアード サイエンシーズ， インコーポレイテッド |
Ｐｄ－１／ｐｄ－ｌ１阻害剤
|
|
CN113185446A
(zh)
*
|
2018-12-06 |
2021-07-30 |
上海济煜医药科技有限公司 |
作为免疫调节的芳环衍生物及其制备方法和应用
|
|
CN110156761B
(zh)
*
|
2019-06-18 |
2022-08-09 |
郑州大学 |
含香豆素-联苯骨架化合物、制备方法及其应用
|
|
CN113880747B
(zh)
*
|
2020-07-03 |
2023-05-26 |
上海美迪西生物医药股份有限公司 |
一种吲哚衍生物及其应用
|
|
CN114163426B
(zh)
|
2020-09-10 |
2024-03-19 |
上海爱博医药科技有限公司 |
苯并含氧杂环类化合物及其医药应用
|
|
CN115340484A
(zh)
*
|
2021-05-13 |
2022-11-15 |
上海美迪西生物医药股份有限公司 |
苄氧基吲哚类支链酸类衍生物及其制备方法和应用
|
|
EP4556465A4
(en)
*
|
2022-11-22 |
2025-10-29 |
Xian Xintong Pharmaceutical Res Co Ltd |
NEW BICYCLIC PD-L1 INHIBITORS, THEIR PREPARATION PROCESSES AND MEDICINAL USES
|
|
WO2025141118A1
(en)
*
|
2023-12-27 |
2025-07-03 |
Institut National de la Santé et de la Recherche Médicale |
Arylalkyloxyindole compounds and derivatives and their use
|